Approaches and Technologies for the Treatment of Diabetes

Diabetes Type 2 is commonly diagnosed on routine screening. High risk factors, also indicate the need for screening, include: older age, obesity, family history of diabetic patient  polycystic ovary syndrome; hypertension; dyslipidemia; or known cardiovascular disease. 

Following approach is used for screening of diabetes : 

  • Fasting plasma glucose (FPG) >125 mg/dL (most common test)
  • Random plasma glucose ≥200 mg/dL with diabetes symptoms such as polyuria, polydipsia, fatigue,  weight loss
  • Two hours post-load glucose ≥200 mg/dL on a 75 g oral glucose tolerance test
  • HbA1c ≥6.5%.

Novel technology for treatment of diabetes

  • Stem Cell Technology
  • Gene Therapy
  • Monoclonal Antibody
  • Telemedicine
  • Artificial pancreas

 

 

  • Bariatric surgery versus conventional therapy
  • Challenges in the selection of innovation into Diabetes
  • Bio- stator:closed loop system
  • Artificial Pancreas and Encapsulation

Related Conference of Approaches and Technologies for the Treatment of Diabetes

September 28-29, 2018

2nd International Conference on Diabetes and Diabetic Nursing Care

Montreal, Quebec, Canada
November 21-22, 2018

14th World Congress on Endocrinology & Diabetes

Paris, France
November 26-27, 2018

26th International Diabetes and Healthcare Conference

Helsinki, Finland
November 26-27, 2018

13th European Diabetes and Endocrinology Congress

Dublin, Ireland

March 28-29, 2019

21st Asia Pacific Diabetes Conference

Osaka,Japan
May 16-17, 2019

2nd Global Meeting on Diabetes and Endocrinology

Abu Dhabi, UAE

28th European Diabetes Congress

June 10-11, 2019 | Edinburgh, Scotland
July 24-25, 2019

29th World Diabetes & Heart Congress

Melbourne, Australia
Oct 03-04, 2019

Euro Diabetes Congress & Expo

| Paris, France

Approaches and Technologies for the Treatment of Diabetes Conference Speakers

Recommended Sessions

Related Journals

Are you interested in